All In MedTech

FDA Clearance Tracker · P880006-S094

SENSOLOG/DIALOG/REGENCY FAMILY OF PACEMAKERS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 12, 2016

Approved

Time to decision

179 days

Received Aug 17, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P880006-S094
Device name
SENSOLOG/DIALOG/REGENCY FAMILY OF PACEMAKERS
Applicant location
Sylmar, CA
Received
Aug 17, 2015
Decided
Feb 12, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P880006

Device type

Device class
Class III

Every decision under product code NIK

FDA's approval statement

As written in FDA's record.

Approval for Quadra Assura MP Cardiac Resynchronization Therapy devices (CRT-Ds) Models CD3269-40, CD3269-40Q, CD3369-40, CD3369-40Q, CD3369-40C, CD3369- 40QC; Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker devices (CRT-Ps) Models PM3160 and PM3262; and Model 3330 Version 21.1 Software for the Model 3650 Merlin Patient Care System Programmer.

Source documents

Other decisions for St. Jude Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.